Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy

被引：0
|
作者：
Min Yang
Hiroyuki Awano
Satoru Tanaka
Walter Toro
Su Zhang
Omar Dabbous
Ataru Igarashi
机构：
[1] Analysis Group,Department of Pediatrics
[2] Inc.,Unit of Public Health and Preventive Medicine
[3] Kobe University Graduate School of Medicine,Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences
[4] Novartis Pharma K.K.,undefined
[5] Novartis Gene Therapies,undefined
[6] Inc.,undefined
[7] Yokohama City University,undefined
[8] The University of Tokyo,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Disease-modifying therapies; Economic burden; Gene therapy; Health-related quality of life; Humanistic burden; Natural history; Nusinersen; Onasemnogene abeparvovec; Spinal muscular atrophy; Systematic literature review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1915 / 1958
页数：43
相关论文
共 50 条
  • [21] Cardiac pathology in spinal muscular atrophy: a systematic review
    C. A. Wijngaarde
    A. C. Blank
    M. Stam
    R. I. Wadman
    L. H. van den Berg
    W. L. van der Pol
    Orphanet Journal of Rare Diseases, 12
  • [22] Cardiac pathology in spinal muscular atrophy: a systematic review
    Wijngaarde, C. A.
    Blank, A. C.
    Stam, M.
    Wadman, R. I.
    van den Berg, L. H.
    van der Pol, W. L.
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [23] Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening-A Systematic Review
    Aragon-Gawinska, Karolina
    Mouraux, Charlotte
    Dangouloff, Tamara
    Servais, Laurent
    GENES, 2023, 14 (07)
  • [24] Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical-Experimental, and Real-World Evidence
    Crisafulli, Salvatore
    Boccanegra, Brigida
    Vitturi, Giacomo
    Trifiro, Gianluca
    De Luca, Annamaria
    BRAIN SCIENCES, 2023, 13 (10)
  • [25] History review of spinal muscular atrophy
    Bieniaszewska, Aleksandra
    Gajewska, Ewa
    AKTUALNOSCI NEUROLOGICZNE, 2022, 22 (01): : 32 - 38
  • [26] Clinical decision making around commercial use of gene and genetic therapies for spinal muscular atrophy
    Waldrop, Megan A.
    NEUROTHERAPEUTICS, 2024, 21 (04)
  • [27] Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers
    Sutherland, C. Simone
    Hudson, Pollyanna
    Mitchell, Stephen
    Paracha, Noman
    PHARMACOECONOMICS, 2022, 40 (SUPPL 1) : 39 - 67
  • [28] The efficacy and safety of Nusinersen for spinal muscular atrophy types 1, 2, 3: a systematic review of the current evidence
    Somaia Daghriri
    Yara A. Alorfi
    Rasil Sulaiman Alayed
    Wid F. Altaf
    Ghaida E. Alharbi
    Hisham Alsulami
    Raghad Alkhalifah
    Omar Alzahrani
    Abdulrahman Softah
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 61 (1)
  • [29] Cognition and communication in patients with spinal muscular atrophy: A systematic review
    Akodad, Sanae
    De Smedt, Delphine
    Baijot, Simon
    Stevens, Hilde
    Deconinck, Nicolas
    HELIYON, 2024, 10 (13)
  • [30] Therapeutic interventions for spinal muscular atrophy: preclinical and early clinical development opportunities
    Servais, Laurent
    Baranello, Giovanni
    Scoto, Mariacristina
    Daron, Aurore
    Oskoui, Maryam
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (05) : 519 - 527
12345